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Endocrine Crosstalk Between
Skeletal Muscle and the Brain
Julien Delezie and Christoph Handschin*
Biozentrum, University of Basel, Basel, Switzerland
Skeletal muscle is an essential regulator of energy homeostasis and a potent coordinator
of exercise-induced adaptations in other organs including the liver, fat or the brain.
Skeletal muscle-initiated crosstalk with other tissues is accomplished though the
secretion of myokines, protein hormones which can exert autocrine, paracrine and
long-distance endocrine effects. In addition, the enhanced release or uptake of
metabolites from and into contracting muscle cells, respectively, likewise can act as a
powerful mediator of tissue interactions, in particular in regard to the central nervous
system. The present review will discuss the current stage of knowledge regarding how
exercise and the muscle secretome improve a broad range of brain functions related to
vascularization, neuroplasticity, memory, sleep and mood. Even though the molecular
and cellular mechanisms underlying the communication between muscle and brain is
still poorly understood, physical activity represents one of the most effective strategies to
reduce the prevalence and incidence of depression, cognitive, metabolic or degenerative
neuronal disorders, and thus warrants further study.
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INTRODUCTION
Exercise Is Powerful Medicine
Physicians increasingly encourage patients to exercise through medical prescriptions of specific
physical activity programs based on the strong epidemiological link between a sedentary life
style and various diseases (1–4). The deleterious effects of physical inactivity often are further
exacerbated by excessive calorie intake resulting in obesity (5, 6). Nevertheless, a sedentary life-
style is a strong and independent risk factor for a range of medical conditions such as cardiovascular
pathologies, diabetes, certain types of cancer, depression, neurological disorders or stroke, for which
the prevalence can be significantly reduced by being active and fit (7–9). However even though the
epidemiological evidence is strong, our knowledge of the molecular and cellular mechanisms by
which exercise promotes health is still rudimentary.
The Science of Exercise
In terms of weight, skeletal muscle is the most abundant organ of the human body. Its function
encompasses the maintenance of postural support, the generation of force and power during
voluntary movements, breathing and thermoregulation. In addition, skeletal muscle accounts for
a large portion of oxidative metabolism and of insulin-stimulated glucose uptake. Moreover, as a
major storage site for glucose, lipids and amino acids, muscle is an essential coordinator of whole-
body energy metabolism. For example, muscle protein metabolism rapidly adapts in response to
physical exercise, dietary protein or anabolic hormones such as insulin-like growth factor 1 or
testosterone (10, 11). The plasticity of skeletal muscle is further illustrated by the myriad of effects
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that either endurance- or resistance-based training induce at the
cellular and molecular levels (12, 13). Recent observations in
rodents and humans have demonstrated the ability of contracting
myofibers to produce and release cytokines and other peptides,
so-called myokines, which play a crucial role in the skeletal
muscle crosstalk with other tissues and, together with muscle-
controlled synthesis and degradation of metabolites, represent an
essential mechanism to control whole-body homeostasis (14).
EXERCISE RESPONSE AND THE
INVOLVEMENT OF MUSCLE PGC-1α
Exercise rapidly triggers substantial changes at the organismal
level depending on various factors, including type, duration
and intensity (13). To optimize contractions, the activity of
the cardiovascular, respiratory, metabolic and neuroendocrine
systems is modulated. At least in part, these adaptations are
initiated from muscle tissue, for example by the paracrine release
of nitric oxide (NO), ATP or reactive oxygen species (ROS)
by myofibers (15). Other changes are mediated by hormonal
signaling, e.g., by glucagon, catecholamines or growth hormones.
For example, hepatic gluconeogenesis and lipolysis in adipose
tissue are stimulated to ensure adequate energy supply to
contracting myofibers (16).
In response to exercise, glycolysis products (i.e., lactate,
pyruvate), lipolysis products (i.e., glycerol), amino acids (i.e.,
alanine and glutamine) and ketone bodies (in particular β-
hydroxybutyrate; BOHB) are found at higher levels in the
circulation (17, 18). Some of these metabolites, for example
lactate and BOHB, are energy substrates for the central nervous
system in the context of limited glucose (19, 20). BOHB and
lactate transport is mediated by monocarboxylate transporters
(MCTs) at the blood-brain barrier (21). Interestingly, exercise
has been associated with changes in the expression of such
transporters (MCT1, 2 and 4) in the rat cortex and hippocampus
Abbreviations: 3HK, Hydroxykynurenine; AICAR, 5-Aminoimidazole-
4-carboxamide ribonucleotide; AMPK, AMP-dependent kinase; BAIBA,
β-Aminoisobutyric acid; BDNF, Brain-derived neurotrophic factor; BMAL1,
Also known as Aryl hydrocarbon receptor nuclear translocator-like protein 1
(Arntl); BOHB, β-Hydroxybutyrate; CREB, Cyclic-AMP-responsive-element-
binding protein; CTSB, Cathepsin B; CXCL-1, CXC ligand 1; DCX, Doublecortin;
ER, Endoplasmic reticulum; ERK1/2, Extracellular signal-regulated kinase; ERRα,
Estrogen-related receptor α; FABP, Fatty-acid-binding protein; FGF21, Fibroblast
growth factor 21; FNDC5, Fibronectin type III domain-containing protein 5; FXR,
Farnesoid X receptor; GLUT4, Glucose transporter 4; HCAR, Hydroxycarboxylic
acid receptors; HDAC, Histone deacetylase; IGF-1, Insulin-like growth factor 1;
IL, Interleukin; KAT, kynurenine aminotransferase; KYN, Kynurenine; KYNA,
Kynurenic acid; LCN2, Lipocalin 2; LIF, Leukemia inhibitory factor; LXRs, Liver
X receptor; MC4R, Melanocortin 4 receptor; MCT, Monocarboxylate transporter;
mTOR, Mechanistic target of rapamycin; NO, Nitric oxide; NREM, Non-rapid eye
movement; NRF, Nuclear respiratory factor; OPA1, mitochondrial fusion protein
optic atrophy 1; PGC-1α, Peroxisome-proliferator activated receptor γ coactivator
1α; PI3K/Akt: Phosphatidylinositol 3-kinase/Akt; PKA, Protein kinase A; PPAR,
Peroxisome-proliferator activated receptor; QUIN, Quinolinic acid; REV-ERBα,
also known as nuclear receptor subfamily 1 group D member 1 (Nr1d1); RORα,
RAR-related orphan receptor alpha; ROS, Reactive oxygen species; RXR, Retinoid
X receptor; SIRT1, Silent mating type information regulation 2 homolog; SPP1,
Secreted phosphoprotein 1; TrkB, Tropomyosin receptor kinase B; VEGF, Vascular
endothelial growth factor.
(22). Notably, lactate and BOHB are not only metabolic fuels
for neuronal cells, but also bind the hydroxycarboxylic acid
receptors (HCARs) and behave as signaling molecules at the
central level (23). For instance, lactate influences neuronal
activity, calcium signaling, axonal myelination, angiogenesis and
memory formation (24, 25). The most abundant free amino acid
in the human body, glutamine, essential as metabolic fuel and a
protein building block, is a potent regulator of multiple signaling
pathways related to inflammation, cell integrity and metabolism
(26, 27). Interestingly, an elevation of glutamine in the rat
hippocampus, striatum, and cerebellum following endurance
exercise has recently been demonstrated (28). However, since
the brain is autonomous for the production of glutamine
and the blood-brain barrier rather impermeable to this amino
acid, a redistribution from skeletal muscle in this context is
rather unlikely (29). Lastly, it is important to highlight the
metabolic coupling between neuronal and glial cells. In particular,
prolonged exercise diminishes brain glycogen essentially stored
in astrocytes providing lactate to adjacent neurons (30, 31). This
lactate shuttle from astrocytes to neurons has been implicated
in long-term memory formation (32), and has been shown to
influence endurance capacity (33).
Exercise-induced cellular stress (e.g., ATP and O2 depletion,
Ca2+ elevation, changes in the NADH/NAD+ ratio and
mechanical stress) leads to the activation of multiple signaling
pathways in skeletal muscle (16). Therefore, exercise is not only
a potent modifier of the metabolome as previously discussed, but
also affects the muscle epigenome, transcriptome and proteome
(34–39). A marked acute exercise-induced hypomethylation of
the promoters of the peroxisome-proliferator activated receptor
γ coactivator 1α (PGC-1α) and the peroxisome-proliferator
activated receptor δ (PPARβ/δ) in human muscle (34) parallels
an upregulation of PGC-1α mRNA and protein stability, in
part via PPARδ-dependent mechanisms (40–43). This PGC-1α-
PPARδ axis plays a pivotal role in the regulation of muscle
mitochondrial metabolism in the initial phase of exercise, and
mediates the increase in mitochondrial biogenesis essential for
endurance training adaptation. Importantly, PGC-1α acts as a
central regulator of mitochondrial dynamics by recruiting and
co-regulatingmultiple transcription factors including the nuclear
respiratory factors NRF-1 and NRF-2, PPARα and PPARδ, and
the estrogen-related receptor α (ERRα) (44–46). The PGC-1α-
ERRα association is essential to coordinate lactate homeostasis
during muscle contraction (47) and mediates exercise-induced
angiogenesis through the induction of VEGF (48, 49). The
active coordination of muscle angiogenesis by PGC-1α is further
illustrated by its ability to induce the release of the secreted
phosphoprotein 1 (SPP1), which recruits macrophages to help
orchestrate multicellular angiogenesis (50). PGC-1α can also
promote remodeling at the neuromuscular junction, which may
be mediated by the secretion of neurturin (51, 52). Overall,
PGC-1α integrates various cell signals during exercise.
The exercise-induced perturbations in the muscle milieu
also lead to the activation of upstream kinases e.g., AMP-
activated protein kinase (AMPK) and deacetylases e.g., SIRT1,
that functionally interact with PGC-1α (53, 54). AMPK is a
conserved energy sensor that is present in all mammalian cells,
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specifically activated in conditions that elevate the AMP:ATP
ratio, with exercise being one of the most powerful activators of
AMPK especially in human muscles (55). Acute exercise induces
AMPK phosphorylation and enzymatic activity in an intensity-
dependent manner, which in turn stimulates ATP production
by promoting glucose transport and fatty-acid oxidation (16).
Noteworthy, peripheral administration of the AMPK agonist
AICAR can enhance running endurance capacity in sedentary
mice. Likewise, a PPARδ agonist (GW501516) induces a gene
program in skeletal muscle related to oxidative metabolism
similar to endurance exercise (56). Whether these and related
compounds are real “exercise mimetics” remains debatable (57).
Intriguingly, treatment of wild-type mice with AICAR, and
to a lesser extent with GW501516, enhances spatial memory
and elevates neurogenesis in the hippocampal dentate gyrus
area, again similar to exercise (58). Surprisingly, the effect
of AICAR on memory function and hippocampal plasticity
is dependent on the expression of the AMPK α2-subunit
in muscle cells, providing evidence for a muscle-mediated
mechanism (59).
THE WHEEL OF HEALTH: NEUROTROPHIC
AND GROWTH FACTORS
In humans, the neurobiological effects of exercise are numerous
e.g., reduction of anxiety and depression, improvement of
social skills and self-esteem as well as mood and cognitive
abilities (60, 61), in concert with significant structural changes
at the central level (62–64). Voluntary exercise in a running
wheel promotes neurogenesis and long-term potentiation in
the adult rodent dentate gyrus (65, 66). Transcriptomic studies
have described changes in gene categories related to chromatin
remodeling, neuronal signaling and plasticity, protein synthesis
and trafficking, and the inflammatory/immune response in
rodent hippocampus after running [reviewed in (67)].
Importantly, one hallmark of physical activity is the central
and peripheral induction of the brain-derived neurotrophic
factor (BDNF). BDNF is a secretory growth factor belonging
to the family of neurotrophins, which supports neural survival,
growth, and synaptic plasticity. BDNF can signal via both TrkB
and p75NTR receptors (68–71) and is induced in the hippocampus
of exercised rats (72). Inhibition of the action of BDNF in the
central nervous system results in a reduction of the recruitment
of the cAMP response-element-binding protein (CREB) to target
sites on genes that mediate the exercise-induced enhancement
in learning and memory (73). Moreover, there is evidence that
physical activity in humans also elevates the level of circulating
BDNF (74, 75). Similarly, BDNF brain and blood levels also
correlate in other species i.e., pigs, rats, and humans (76).
Notably, besides the brain as a potential source, a substantial
amount of circulating BDNF originates from megakaryocytes,
precursors of blood platelets; hence, the variations in BDNF in
exercise studies could be caused by the different activation level
of human platelets (77). The contribution of platelets to the
exercise effects, in particular on the brain, remains unexplored
(78), even though BDNF could be transported in platelet-
derived vesicles to the brain (79). Unlike humanmegakaryocytes,
this cell population is not involved in BDNF synthesis in the
mouse (77). In contrast, BDNF is produced and secreted by
human and rodent skeletal muscles and is regulated by exercise
(80, 81). Muscle BDNF seems mostly involved in autocrine
and paracrine signaling to promote muscle fiber fat oxidation
and potentially muscle development (81–83), as well as in the
retrograde signaling on motor neurons located in the spinal cord
(84). Whether muscle-derived BDNF also signals to the brain,
e.g., via TrkB signaling at the blood-brain barrier (85), remains
to be investigated.
The blood-brain barrier consists of endothelial cells, vascular
smooth cells, pericytes, basement membranes and astrocytic feet
along cerebral microvessels, regulating the exchange between
blood and neural tissue. This neurovascular interface acts as a
barrier, limiting or facilitating the entry of specific nutrients,
metabolites and hormones. For example, the hormone insulin-
like growth factor-1 (IGF-1), mainly produced by the liver,
can cross the blood-brain barrier and act as a mediator of
the exercise-induced changes in hippocampal neurogenesis and
BDNF expression (86, 87). Importantly, the formation and
maintenance of dendritic spines in hippocampal neurons in
basal conditions depend on the BDNF-dependent induction of
PGC-1α after exercise (88, 89). In neuronal tissue, PGC-1α is
a potent suppressor of ROS and thus exerts neuroprotective
effects (90). Interestingly, long-term voluntary running exercise
can slow down the progression of some neurodegenerative
or age-related central deteriorations in mice (91–93). This is
consistent with data emerging from human studies, in which
aerobic exercise moderately prevents or delays the onset of
aging- and neurodegeneration-associated memory loss (94–
96). Noteworthy, neurogenesis in rodents occurs within an
angiogenic niche (97) and exercise-induced vascularization is
mediated in part by circulating vascular endothelial growth
factor [VEGF; (98)]. Moreover, peripheral blockade of VEGF
abolishes running-induced neurogenesis (99). Importantly, other
neurotrophic factors are regulated by physical exercise in
rodents. For instance, the expression of the glial cell line-derived
neurotrophic factor or neurotrophin-3 is affected by physical
exercise in skeletal muscle, the spinal cord, or the brain (100–
103). These results thus suggest that molecules other than BDNF
could alsomediate the neuroprotective effects of physical exercise
at the central level [discussed in (104)].
Altogether, a combination of blood-born factors and centrally-
expressed genes is required to promote angiogenesis and
neurogenesis at the central level. Future studies are needed to
characterize how IGF-1, VEGF and, putatively, BDNF signaling is
integrated by neurons, and how exercise impacts the endothelial
and glial cell populations at the blood-brain interface.
FROM SKELETAL MUSCLE TO THE BRAIN:
INVOLVEMENT OF MYOKINES AND
METABOLITES
Since the discovery of interleukin-6 (IL-6) as a cytokine produced
by and released from skeletal muscle (105), various other
exercise-induced factors have been identified by biochemical
(106–108), proteomic (109, 110), or transcriptomic approaches
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(106, 111). These factors, called myokines, have autocrine,
paracrine and/or endocrine effects [for review, see (14, 112)].
Importantly, the muscle secretome is not limited to protein
hormones, as muscle cells also release or remove circulating
metabolites. For instance, forced overexpression of PGC-
1α in myocytes triggers the production and release of β-
aminoisobutyric acid (BAIBA), which modulates both liver and
fat metabolism (113). In this review, we focus on the recently
described mediators of the muscle-to-brain communication
(Table 1).
Irisin
In 2002, two studies reported the discovery of a cDNA encoding
a novel protein, PeP/Frcp2, now named FNDC5 (124, 125). The
secreted form of FNDC5, irisin, is a PGC-1α-dependent myokine
induced by exercise (126). Noteworthy, irisin circulates at levels
close to essential metabolic hormones (e.g., insulin, leptin) in
humans (127), and acts on subcutaneous fat, promoting the
beigeing and thermogenic program of white adipocytes, thereby
increasing energy expenditure (126, 128).Moreover, irisin has the
potential to modulate muscle and liver cell metabolism in vitro
[reviewed in (129)]. Interestingly, FNDC5 has been detected in
different areas of the brain (124, 125) and has been associated
with neural differentiation (130). Additional evidence implies
that FNDC5/irisin is also a part of the transcriptional response
to exercise in the mouse hippocampus along with PGC-1α
and BDNF (89). Mechanistically, the study demonstrated that
the PGC-1α-dependent induction of FNDC5 in both primary
cortical and hippocampal neurons involves the transcription
factor ERRα. Moreover, FNDC5 is required to induce BDNF in
a cell-autonomous manner, and recombinant BDNF treatment
decreased FNDC5 expression as a part of a negative feedback
loop.Most strikingly, the elevation of circulating levels of irisin by
adenoviral overexpression of FNDC5 in the liver increased BDNF
expression in the mouse hippocampus, but not in the forebrain.
Collectively, these data reveal a cellular mechanism by which
endurance exercise promotes hippocampal gene expression such
as BDNF and PGC-1α related to neuroprotection and memory.
While it is unclear whether peripheral or central irisin mediate
these effects in the brain, the adenoviral overexpression raises
the possibility that circulating irisin could cross the blood-brain
barrier, or act on receptors expressed by endothelial cells, to
further amplify the effect of exercise on the central nervous
system. In that regard, the deletion of FNDC5 in brain or skeletal
muscle cells, together with the identification of its receptor,
may delineate the exact contribution of systemic vs. local/central
irisin. This seems especially important as modulation of central
vs. peripheral irisin levels differently affects blood pressure in
rodents (131).
Cathepsin B
The cysteine protease cathepsin B (CTSB) is ubiquitously
expressed throughout the body, including human muscle cells
during exercise (109, 132). In the search of muscle-produced
factors using a mass spectrometry-based approach, Moon et al.
(114) exposed rat myotubes to the AMPK agonist AICAR and
identified CTSB as a putative myokine. The authors further
demonstrated that short-term AICAR treatment was effective in
inducing Ctsb mRNA in myotubes. Moreover, 30 days of wheel-
running activity upregulated Ctsb mRNA in the hippocampus
and the gastrocnemius muscle (but not in other organs e.g.,
liver or adipose tissue), as well as plasma levels of CTSB in
mice. Likewise, 4 months of treadmill exercise led to a significant
increase of plasma CTSB concentrations in rhesus monkeys and
humans. Furthermore, Moon et al. (114) showed that CTSB has
the property to cross the blood-brain barrier and the application
of exogenous CTSB to hippocampal progenitor cells induced
both BDNF and doublecortin (DCX) transcripts. Strikingly,
physical activity did not promote hippocampal neurogenesis
or improved spatial memory in whole-body CTSB KO mice,
suggesting that central and/or muscle-derived CTSB could
mediate the beneficial effects of physical activity on memory
function in rodents. Whether a correlation between human
plasma CTSB levels and fitness or memory scores exists, as
suggested by the authors, remains to be confirmed. Likewise, it is
not clear if a therapeutic elevation of blood CTSB levels would be
sufficient to enhance hippocampal-dependent memory function,
especially in the aging context. Besides, the physiological effects
of chronic exogenous CTSB administration have to be addressed,
in particular in light of its involvement in inflammation, cell
apoptosis, tumor development and progression (133, 134). Lastly,
the signaling pathway by which peripheral and/or central CTSB
promotes BDNF elevation and neurogenesis is still unknown.
L-Lactate
A recent study has uncovered a cellular mechanism by which
blood-born lactate from contracting muscles signals to the brain
to promote angiogenesis. Morland et al. (115) investigated the
putative role the hydroxycarboxylic acid receptor 1 (HCAR1),
enriched at the blood-brain barrier (135), as a mediator of
lactate-induced central vascularization. They observed that after
7 weeks of wheel-running activity, mice lacking HCAR1 did
not show increased VEGFA expression and capillary density in
the dentate gyrus or the sensorimotor cortex. Similarly, chronic
subcutaneous injections of sodium L-lactate failed to enhance
VEGFA expression and vascularization in HCAR1 KO animals,
indicating that HCAR1 is essential to mediate the effects of
exercise on angiogenesis in specific brain areas. Moreover, in line
with the involvement of the phosphatidylinositol 3-kinase/Akt
(PI3K/Akt) and extracellular signal-regulated kinase (ERK1/2)
signaling pathways in mediating the induction of VEGF (136),
both lactate and a selective HCAR1 agonist failed to activate
ERK1/2 and Akt in hippocampal slices lacking HCAR1. The
authors further defined the location of the HCAR1 protein in
the leptomeningeal fibroblast-like cells of the pia mater—the
innermost layer of the meninges which supports blood vessel—
as well as pericyte-like cells, previously shown to be involved in
the control of blood flow and angiogenesis (137).
Kynurenin and Kynurenic Acid
The underlying cause of depression is difficult to elucidate as
a combination of biological, psychological and environmental
factors contribute to the pathogenesis of this disease. Notably
however, depressed patients are usually less physically active,
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TABLE 1 | Overview of muscle-derived and exercise-induced endocrine signals involved in the periphery-brain crosstalk.
Protein or
metabolite
Tissue Experimental models Detected
in blood
Transport/
receptor
Central effects Main
references
IDENTIFIED AND PUTATIVE MUSCLE-DERIVED FACTORS TRIGGERED BY EXERCISE
Cathepsin B Skeletal muscle CTSB KO mice
Rat myotubes + AICAR treatment
Peripheral CTSB injection
Human
Rhesus
Monkey
Mouse
BBB
crossing/
?
↑ Hippocampal neurogenesis +
spatial memory
↑ Hippocampal BDNF + DCX
(114)
Irisin Brain
Skeletal
muscle
PGC-1α KO mice
Adenovirus-mediated
overexpression of PGC-1α
(neurons) and FNDC5 (liver)
Human
Mouse
BBB
crossing/
?
↑ Hippocampal BDNF (89)
L-Lactate Skeletal muscle HCAR1 KO mice
Exogenous L-lactate injection
Human
Mouse
MCTs/HCAR1
at the BBB
↑ Vascularization
↑ VEGFA expression and
vascularization
(115)
? Skeletal muscle Peripheral AICAR injection
Deletion of the AMPK α2-subunit
in mouse muscle
? ? ↑ Hippocampal neurogenesis +
spatial memory
(58, 59)
Protein or
metabolite
Tissue/stimulus Experimental models Detected
in blood
Transport/
receptor
Central effects Main
references
ADDITIONAL FACTORS (NOT NECESSARILY INDUCED BY PHYSICAL ACTIVITY OR DERIVED FROM SKELETAL MUSCLE)
β-hydroxybutyrate Liver (fasting + PA) Exercise mouse
Central β-hydroxybutyrate
injection
shRNA-mediated KD of HDAC3
Human
Mouse
MCTs and
HCARs at the
BBB
↓ HDAC2 and HDAC3
recruitment at Bdnf promoters
↑ Hippocampal BDNF
↑ Glutamate release
(116)
Fibroblast growth
factor 21
Liver (PA)
Adipose Skeletal
muscle
Peripheral and central FGF21
injection
Overexpression of FGF21 in
mouse liver
Deletion of β-Klotho in mouse
brain
Human
Mouse
BBB
crossing/βKlotho,
FGFR1
Regulation of metabolism,
energy expenditure, and
circadian behavior
(117–119)
Insulin-like growth
factor-1
Liver (PA) Exercise rat
Peripheral IGF-1 injection
Anti-IGF-1 antibody + IGF-1
receptor antagonist
Human
Rat
Mouse
BBB
crossing/IGF-
1 receptor at
the BBB
↑ Hippocampal neurogenesis
and BDNF expression
(86, 87, 120)
Kynurenin (KYN)
Kynurenic acid
(KYNA)
Liver
Skeletal muscle
(PA)
Exercise mouse
Overexpression/deletion of
PGC-1α in mouse muscle
Peripheral KYN injection
Human
Mouse
KYN can
cross the
BBB but not
KYNA/ ?
↓ KYN accumulation decreases
stress-induced neurobiological
mechanisms of depression
(121, 122)
? Skeletal muscle Mouse global, brain- or
muscle-specific
deletion/overexpression of
BMAL1
? ? Regulation of NREM sleep time
and sleep recovery following
sleep deprivation
(123)
BBB, blood-brain barrier; PA, physical activity.
and the effectiveness of exercise programs in reducing depressive
symptoms has been widely recognized (138, 139). Kynurenine
(KYN) is a metabolite of the amino acid L-tryptophan, primarily
synthetized in the liver. The degradation of KYN follows
two different pathways: one proceeds with the conversion
of KYN to 3-hydroxykynurenine (3HK) and quinolinic acid
(QUIN), while the alternative pathway converts KYN to
kynurenic acid (KYNA). In the brain, the conversion to
KYNA is catalyzed by kynurenine aminotransferases (KATs)
found in astrocytes. The same enzymes are expressed in
different peripheral tissues including skeletal muscle (140, 141).
Importantly, evidence suggests that a dysregulation of the
KYN pathway is associated with a number of psychiatric
disorders such as depression (140, 141). In a study from
Agudelo et al. (121), exercise has been shown to activate
the expression of KATs through a PGC-1α- and PPARα/δ-
dependent pathway in both mouse and human muscles.
Consistently, overexpression of PGC-1α and loss of PGC-
1α, respectively, resulted in increased and decreased muscle
KAT expression levels. The increase in KATs expression in
the gain-of-function model shifted KYN metabolism toward
enhanced synthesis of KYNA, which is unable to cross the
blood-brain barrier, thereby reducing the accumulation of plasma
KYN with its neurotoxic effects on the brain. Remarkably,
this shift conferred resistance to chronic mild stress-induced
depression in mice overexpressing PGC-1α in their muscles.
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The authors furthermore demonstrated that muscle PGC-
1α elevation prevented the alterations in the expression of
neurotrophic, synaptic and pro-inflammatory markers in the
hippocampus in response to chronic mild stress and, to a lesser
extent, exogenous KYN administration. These data suggest that
physical exercise could also affect neuroinflammation [reviewed
in (142, 143)].
These findings further illustrate how muscle PGC-1α can
mediate the benefits of exercise in the crosstalk between skeletal
muscle and the brain. Incidentally, a new observation in
healthy individuals confirmed that regular endurance training
promotes skeletal muscle KATs gene and protein expression,
along with enhanced peripheral conversion of KYN to KYNA
(122). Moreover, the “detoxifying” potential of skeletal muscle
may not be limited to KYNA, as muscle PGC-1α also regulates
systemic ketone body levels and can prevent hyperketosis (144).
β-Hydroxybutyrate
The transcriptional regulation of BDNF in the hippocampus at
least in part depends on the modulation of histone acetylation
(145). By comparing sedentary mice to mice that had running-
wheel access for 30 days, Sleiman et al. (116) found that exercise
induced changes in class I HDAC expression, a family of proteins
that suppress gene expression by deacetylating lysine residues
on histone and non-histone proteins. In particular, binding of
HDAC2 and HDAC3 to the hippocampal Bdnf promoter I and II
was reduced in exercising mice, leading to elevated BDNF levels.
Interestingly, besides its role as energy source, the ketone body
BOHB also acts as an epigenetic signaling molecule by inhibiting
class I HDACs (23). Sleiman and colleagues hypothesized that
this exercise factor might inhibit the action of the histone
deacetylases on the Bdnf promoter. They showed that exercise
induces BOHB accumulation in the hippocampus and that the
direct injection of BOHB into the ventricles of mice led to
higher BDNF expression. In addition, application of BOHB
to primary neurons decreased HDAC3 binding to the Bdnf
promoter, whereas the use of a selective HDAC3-inhibitor or the
knockdown of HDAC3 by shRNA increased BDNF expression.
This effect on BDNF expression appeared specific, as BOHB did
not induce Pgc-1α, Fndc5, or Errα mRNA in primary neurons.
The authors also found that the increase of BDNF by BOHB led
to enhanced glutamate release in hippocampal slices, and that
this effect was dependent on TrkB signaling. The potential of
BOHB to convey peripheral information to the brain is further
illustrated by other findings demonstrating that liver-derived
BOHB modulates neural network-based prediction of feeding
time in mice (146).
Muscle Bmal1
Sleep is a critical health function that is controlled by complex
mechanisms distributed in multiple brain areas such as the
cortex, the brain stem and the hypothalamus (147). Circadian
clocks are located in nearly every cell of the mammalian body
and generate molecular rhythms with a 24-h period, essential
to adjust the behavior and physiology of an organism to the
external environment (148). In the past, several studies in mice
and humans have demonstrated the consequence of genetic clock
perturbations on sleep homeostasis (149, 150). In particular,
global deletion of the core clock gene Bmal1 in mice can affect
sleep processes, with longer non-rapid eye movement (NREM)
sleep time and altered sleep response after a period of sleep loss
(151). Recent findings from Ehlen et al. (123) have challenged the
common view that sleep is a process that is only influenced by the
brain. They found that restoring Bmal1 expression in the brain
of whole-body Bmal1 KO mice failed to normalize NREM sleep
amount to control values, suggesting that Bmal1 in another tissue
might be important to regulate sleep physiology. Indeed, rescuing
Bmal1 in skeletal muscle was sufficient to restore NREM sleep
amount as well as sleep recovery after sleep loss. A causative role
for muscle Bmal1 was further supported by the fact that Bmal1
deletion only in skeletal muscle recapitulated the sleep alterations
seen in whole-body Bmal1 KO mice, whereas overexpression of
Bmal1 in skeletal muscle of wild-type mice renders mice resistant
to sleep deprivation.
These results are intriguing for several reasons. First, they
suggest for the first time that a single gene in a peripheral tissue
can modulate essential centrally-generated sleep processes—
whether this depends on the BMAL1 association with CLOCK
or other partners in muscle cells has to be investigated. Second,
these data imply a muscle-to-brain signaling involved in sleep
regulation, either humoral, or, based on the observation that
mice lacking Bmal1 in their muscles exhibit potent metabolic
disruptions (152, 153), via metabolites. Third, because restoring
Bmal1 expression in muscle cells does not restore circadian
rhythmicity (154), and more importantly here, the diurnal
rhythm of NREM sleep, it is possible that the production
and secretion of this muscle-derived factor is a time-controlled
cellular event. In the same line of thought, it would be interesting
to evaluate whether scheduled exercise, in addition to muscle
Bmal1 reintroduction, is able to reinstate sleep phase timing in
this mouse model.
PUTATIVE CANDIDATES, NETWORK AND
FUTURE RESEARCH
Cytokines
Contraction-induced release of IL-6 has potent effects on whole-
body glucose disposal (105). Interestingly, IL-6 can act locally
on muscle cell glucose uptake and fatty acid oxidation in an
autocrine/paracrine manner (155). Systemic elevation of IL-6 by
exogenous administration or exercise stimulates insulin release
from pancreatic cells (156) and mediates fasting-induced free
fatty acid mobilization by adipose tissue (157) as an endocrine
hormone. Importantly, other cytokines, e.g., IL-8 and IL-15
mRNA, are also upregulated upon exercise in skeletal muscle
and have the potential to behave as myokines [reviewed in
(112)]. Additional evidence suggests that the murine chemokine
CXC ligand 1 (CXCL-1) and the leukemia inhibitory factor
(LIF)—belonging to the IL-6 cytokine superfamily—are both
produced by contracting muscle cells and may exert local or
long-distance actions [reviewed in (158)]. Likewise, in vitro data
from primary human myotubes further suggest a broader muscle
cytokines response to exercise (108). Interestingly, most of these
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cytokines are neuromodulators when expressed by neurons and
glial cells, potentially influencing brain health and disease (159).
This is especially evidenced in the context of higher central or
peripheral level of pro-inflammatory cytokines, which reduce
central BDNF expression and thus impact on neurogenesis
and neurotransmitter release (160, 161). It is currently unclear
whether all of these cytokines are released from muscle fibers or
from resident immune cells in this tissue. Moreover, a potential
crosstalk between muscle and brain remains to be shown:
potentially, cytokine signaling at the blood-brain interface might
be important to modulate aspects of brain physiology such as
sleep, memory or feeding behavior.
FGF21
Fibroblast growth factor 21 (FGF21) is an endocrine hormone
expressed by several tissues including skeletal muscle, adipose
tissue and pancreas. The main source of FGF21 is the liver
during prolonged fasting, presumably via PPARα- and PGC-1α-
dependent mechanisms, resulting in a modulation of systemic
energy balance, insulin sensitivity, hepatic gluconeogenesis and
glucocorticoid levels (162). Importantly, FGF21 can cross the
blood-brain barrier and is found in both human and mouse
cerebrospinal fluid (163, 164). Moreover, FGF21 signals in the
brain through its co-receptor, βKlotho, as well as the FGF
receptor-1, located in the hypothalamus (117, 162). Proposed
effects for FGF21 in the nervous system are the modulation of the
sympathetic nerve input to brown adipose tissue, the control of
circadian behavior, and neuroprotection (117, 119, 165). Studies
also suggest that FGF21 can be produced by muscle cells in
certain context involving e.g., the activation of AKT or the
mTORC1 pathway (166–169). Pereira et al. (170) demonstrated
that a muscle deficiency of the mitochondrial fusion protein
optic atrophy 1 (OPA1) alters mitochondrial dynamics and
increases endoplasmic reticulum (ER) stress, thereby promoting
muscle-FGF21 release and rendering mice resistant to age-
and diet-induced obesity and insulin resistance. The molecular
mechanism by which ER-stress activates FGF21 is not clear, but
could involve the transcriptional co-regulator PGC-1α (171, 172).
Of interest, one study showed increase serum FGF21 levels in
mice and humans after exercise, yet likely of liver and not
skeletal muscle or adipose tissue origin (118). In summary,
FGF21 can be considered as an hepatokine, adipokine, and
potentially a myokine, and has various effects at the whole-
body level including the nervous system. Thereby, future research
should investigate the putative involvement of FGF21 in the
muscle-brain crosstalk, especially during exercise.
Inter-cell Crosstalk
Skeletal muscle is a part of a larger system which also
encompasses bones, tendons, ligaments, cartilage, joints, nervous
and connective tissues. In particular, beyond their mechanical
coupling, bone and muscle cells can communicate at the
biochemical and molecular levels underlining a potential
paracrine/endocrine crosstalk. Different studies demonstrated
an effect of muscle-specific gene deletion or overexpression
on bone physiology [reviewed in (173, 174)], and a close
correlation between bone and muscle deterioration during aging
(175). As in other cell types, different bone cell types have
the capacity to release factors into the circulation (176). For
instance, the osteoblast-secreted protein osteocalcin is essential
to regulate energy metabolism by increasing insulin sensitivity
via the stimulation of adiponectin release by adipocytes (177).
Intriguingly, mouse and human data showed that circulating
osteocalcin levels are increased upon exercise, and greatly
diminished during aging. Moreover, bone-derived osteocalcin
signals to muscle cells and favors the uptake and utilization
of glucose and fatty acids in addition to stimulate muscle
secretion of IL-6, which again feedbacks to bone cells to enhance
osteocalcin production (178). Mosialou et al. (179) revealed that
the bone-derived glycoprotein lipocalin 2 (LCN2), a previously
identified component of the immune response (180), crosses the
blood-brain barrier and binds to the melanocortin 4 receptor
(MC4R) in the paraventricular and ventromedial neurons of the
hypothalamus to inhibit food intake. Lipocalin 2 is also produced
in muscle cells under the control of PGC-1α (181).
These findings implicate crosstalk of skeletal muscle
with more dispersed peripheral cells. For instance, physical
exercise induces the secretion of the adipose-derived hormone
adiponectin, which enhances hippocampal neurogenesis and
has potent antidepressant effects (182). Interestingly, a role for
muscle IL-15 has been suggested in the regulation of adiponectin
production (183).
The Circadian Muscle Secretome
Circadian clocks control myriad of processes such as gene
regulation, protein synthesis and export, enzyme activity, cell
signaling, nutrient accumulation, on a 24-h time scale. Moreover,
clock proteins are cellular sensors, in that they can integrate
specific changes in the external or internal environment (184).
Chronic circadian disruption by irregular sleep-wake cycles
or meal timing has been associated with obesity and other
metabolic conditions, cancer and inflammation, sleep as well as
cognitive and mental disorders (185–188). In skeletal muscle,
the molecular clock has been linked to cell growth and repair,
autophagy, insulin sensitivity, lipid homeostasis, mitochondrial
metabolism and respiration (152, 189–191). Moreover, scheduled
exercise is a potent stimulus to regulate circadian timing
in skeletal muscle (192, 193). Interestingly, human primary
myotubes harbor a cell-autonomous circadian clock involved in
the basal release of cytokines (e.g., IL-6, IL-8) and other proteins
(e.g., VEGF, FABP) as identified by ELISA and multiplex assays
(194). Intriguingly, Pgc-1α transcript oscillates in skeletal muscle
and PGC-1α can co-activate RORα to induce the expression
of Bmal1 in primary hepatocytes (195). Furthermore, genetic
ablation of Bmal1 from muscle cells gave evidence that a
peripheral clock function is essential for centrally-controlled
sleep processes (123). Thereby, it is likely that a transcriptional
regulatory network, involving circadian nuclear receptors and
the coactivator protein PGC-1α coordinates the time-of-day-
dependent accumulation of myokines in muscle cells and
secretion into the circulation. Future work should for instance
evaluate the temporal phase relationship between core clock
components and muscle-derived factors. Moreover, if part of the
muscle secretome is gated by the circadian clock as in other
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endocrine organs (196), there are certainly time windows during
which exercise can exert maximal effects on brain physiology.
Altogether, there is a likely bidirectional influence between
circadian and exercise pathways in muscle cells—whether this is
important for skeletal muscle endocrine function requires further
investigation. In any case, at the organismal level, circadian clocks
clearly provide a molecular basis by which endocrine signaling—
i.e., from the production and secretion of an endocrine factor to
the activation of a signaling pathway—can be achieved in a timely
fashion. Given the conserved relation between circadian clock
and neuronal function (197–201), time-based physical activity
interventions may potentiate the health benefits of exercise.
CONCLUSION
Genetic engineering and the relentless motivation of captive
rodents to be active on an exercise wheel have given scientists
the opportunity to identify several muscle-derived signaling
factors (Figure 1). At the central level, BDNF is a crucial
mediator of the effects of exercise for the modulation of
synaptic transmission, neurogenesis and memory function.
In skeletal muscle, PGC-1α exerts a strong “detoxifying”
potential and is an effective regulator of the muscle secretome,
essential for exercise adaptations and the regulation of central
function such as memory and mood. However, the timing
and regulation of myokine production and secretion are still
poorly understood. For many putative myokines, a thorough
characterization and validation is still lacking [discussed
in (14)]. Moreover, discrepancies in the identification of
putative myokines have been emerging in studies in cell-
based compared to in vivo models (202). Finally, for most
of these factors it is unclear whether peripheral or central
production is mediating the beneficial effects on the brain.
Nevertheless, the strong epidemiological evidence of exercise as
a powerful intervention to prevent and treat various pathologies
warrants a careful dissection of the signals, networks and
FIGURE 1 | Muscle-brain crosstalk. Physical exercise activates specific cellular pathways in muscle cells. For instance, PGC-1α activation induces the expression of
FNDC5, which is cleaved to irisin and released into the circulation. PGC-1α elevation also leads to the biosynthesis of kynurenine aminotransferases (KATs) which
converts liver-derived KYN to KYNA, thus preventing its toxic accumulation into the brain. The endocrine property of muscle cells is further illustrated by the release of
cytokines (e.g., IL-6) or metabolites (e.g., lactate). Physical activity also promotes the production and release into the blood of various factors from non-muscle tissues
such as the liver. Subsequently, muscle- and liver-derived molecules enter the brain and signal on receptors located on endothelial, glial or neuronal cells, thereby
triggering the expression of VEGF and BDNF, key regulators of cerebral vascularization and plasticity.
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mediators of the inter-organ crosstalk originating from skeletal
muscle. This is of particular importance for neurological
disorders, where therapeutic options are scarce and desperately
needed.
AUTHOR CONTRIBUTIONS
All authors listed have made a substantial, direct and intellectual
contribution to the work, and approved it for publication.
FUNDING
The work in our laboratory is funded by the Swiss National
Science Foundation, the European Research Council (ERC)
Consolidator grant 616830-MUSCLE_NET, Swiss Cancer
Research grant KFS-3733-08-2015, the Swiss Society for Research
on Muscle Diseases (SSEM), SystemsX.ch, the Novartis Stiftung
für Medizinisch-Biologische Forschung and the University of
Basel.
REFERENCES
1. Ding D, Lawson KD, Kolbe-Alexander TL, Finkelstein EA, Katzmarzyk PT,
van Mechelen W, et al. The economic burden of physical inactivity: a global
analysis of major non-communicable diseases. Lancet (2016) 388:1311–24.
doi: 10.1016/S0140-6736(16)30383-X
2. Lobelo F, Stoutenberg M, Hutber A. The exercise is medicine global
health initiative: a 2014 update. Br J Sports Med. (2014) 48:1627–33.
doi: 10.1136/bjsports-2013-093080
3. Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing
exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports
(2015) 25 (Suppl. 3):1–72. doi: 10.1111/sms.12581
4. Sallis RE. Exercise is medicine and physicians need to prescribe it! Br J Sports
Med. (2009) 43:3–4. doi: 10.1136/bjsm.2008.054825
5. NCD Risk Factor Collaboration (2017). Worldwide trends in body-
mass index, underweight, overweight, and obesity from 1975 to 2016:
a pooled analysis of 2416 population-based measurement studies in
128.9 million children, adolescents, and adults. Lancet 390, 2627–2642.
doi: 10.1016/S0140-6736(17)32129-3
6. Lobstein T, Baur L, Uauy R. Obesity in children and young
people: a crisis in public health. Obesity Rev. (2004) 5:4–85.
doi: 10.1111/j.1467-789X.2004.00133.x
7. Ekelund U, Steene-Johannessen J, Brown WJ, Fagerland MW, Owen N,
Powell KE, et al. Does physical activity attenuate, or even eliminate, the
detrimental association of sitting time with mortality? A harmonised meta-
analysis of data from more than 1 million men and women. Lancet (2016)
388:1302–10. doi: 10.1016/S0140-6736(16)30370-1
8. Handschin C, Spiegelman BM. The role of exercise and PGC1alpha
in inflammation and chronic disease. Nature (2008) 454:463–9.
doi: 10.1038/nature07206
9. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the
evidence. CMAJ (2006) 174:801–9. doi: 10.1503/cmaj.051351
10. Koopman, R., and van Loon, L. J. Aging, exercise, and muscle
protein metabolism. J Appl Physiol. (1985) (2009) 106:2040–8.
doi: 10.1152/japplphysiol.91551.2008
11. Rooyackers OE, Nair KS. Hormonal regulation of human
muscle protein metabolism. Annu Rev Nutr. (1997) 17:457–85.
doi: 10.1146/annurev.nutr.17.1.457
12. Bassel-Duby R, Olson EN. Signaling pathways in skeletal
muscle remodeling. Annu Rev Biochem. (2006) 75:19–37.
doi: 10.1146/annurev.biochem.75.103004.142622
13. Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative biology of
exercise. Cell (2014) 159:738–49. doi: 10.1016/j.cell.2014.10.029
14. Whitham M, Febbraio MA. The ever-expanding myokinome: discovery
challenges and therapeutic implications. Nat Rev Drug Discov. (2016)
15:719–29. doi: 10.1038/nrd.2016.153
15. Sylow L, Kleinert M, Richter EA, Jensen TE. Exercise-stimulated glucose
uptake - regulation and implications for glycaemic control. Nat Rev
Endocrinol. (2017) 13:133–48. doi: 10.1038/nrendo.2016.162
16. Egan B, Zierath JR. Exercise metabolism and the molecular regulation
of skeletal muscle adaptation. Cell Metab. (2013) 17:162–84.
doi: 10.1016/j.cmet.2012.12.012
17. Henriksson J. Effect of exercise on amino acid concentrations in skeletal
muscle and plasma. J Exp Biol. (1991) 160:149–65.
18. Lewis GD, Farrell L, Wood MJ, Martinovic M, Arany Z, Rowe GC, et al.
Metabolic signatures of exercise in human plasma. Sci Transl Med. (2010)
2:33ra37. doi: 10.1126/scitranslmed.3001006
19. Schurr A. Lactate: the ultimate cerebral oxidative energy substrate? J Cereb
Blood Flow Metab. (2006) 26:142–52. doi: 10.1038/sj.jcbfm.9600174
20. van Hall G, Stromstad M, Rasmussen P, Jans O, Zaar M, Gam C, et al. Blood
lactate is an important energy source for the human brain. J Cereb Blood Flow
Metab. (2009) 29:1121–9. doi: 10.1038/jcbfm.2009.35
21. Bergersen LH. Lactate transport and signaling in the brain: potential
therapeutic targets and roles in body-brain interaction. J Cereb Blood Flow
Metab. (2015) 35:176–85. doi: 10.1038/jcbfm.2014.206
22. Takimoto M, and Hamada T. Acute exercise increases brain region-specific
expression of MCT1, MCT2, MCT4, GLUT1, and COX IV proteins. J Appl
Physiol. (2014).116:1238–50. doi: 10.1152/japplphysiol.01288.2013
23. Newman JC, Verdin E. β-Hydroxybutyrate: a signaling metabolite.Annu Rev
Nutr. (2017) 37:51–76. doi: 10.1146/annurev-nutr-071816-064916
24. Barros LF. Metabolic signaling by lactate in the brain. Trends Neurosci.
(2013) 36:396–404. doi: 10.1016/j.tins.2013.04.002
25. Ruan GX, Kazlauskas A. Lactate engages receptor tyrosine kinases Axl,
Tie2, and vascular endothelial growth factor receptor 2 to activate
phosphoinositide 3-kinase/Akt and promote angiogenesis. J Biol Chem.
(2013) 288:21161–72. doi: 10.1074/jbc.M113.474619
26. Brasse-Lagnel C, Lavoinne A, Husson A. Control of mammalian gene
expression by amino acids, especially glutamine. Febs j (2009) 276:1826–44.
doi: 10.1111/j.1742-4658.2009.06920.x
27. Curi R, Newsholme P, Procopio J, Lagranha C, Gorjao R, Pithon-Curi TC.
Glutamine, gene expression, and cell function. Front Biosci J Virtual Libr.
(2007) 12:344–57. doi: 10.2741/2068
28. Swiatkiewicz M, Fiedorowicz M, Orzeł J, Wełniak-Kaminska M, Bogorodzki
P, Langfort J, et al. Increases in brain 1H-MR glutamine and glutamate signals
following acute exhaustive endurance exercise in the rat. Front Physiol.
(2017) 8:19. doi: 10.3389/fphys.2017.00019
29. Hawkins RA. The blood-brain barrier and glutamate. Am J Clin Nutr. (2009)
90:867S−74S. doi: 10.3945/ajcn.2009.27462BB
30. Machler P, Wyss MT, Elsayed M, Stobart J, Gutierrez R, von Faber-Castell A,
et al. In vivo evidence for a lactate gradient from astrocytes to neurons. Cell
Metab. (2016) 23:94–102. doi: 10.1016/j.cmet.2015.10.010
31. Matsui T, Ishikawa T, Ito H, Okamoto M, Inoue K, Lee MC, et al. Brain
glycogen supercompensation following exhaustive exercise. J Physiol. (2012)
590:607–16. doi: 10.1113/jphysiol.2011.217919
32. Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ,
et al. Astrocyte-neuron lactate transport is required for long-term memory
formation. Cell (2011) 144:810–23. doi: 10.1016/j.cell.2011.02.018
33. Matsui T, Omuro H, Liu Y-F, Soya M, Shima T, McEwen BS, et al.
Astrocytic glycogen-derived lactate fuels the brain during exhaustive exercise
to maintain endurance capacity. Proc Natl Acad Sci USA. (2017) 114:6358–
63. doi: 10.1073/pnas.1702739114
34. Barres R, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, et al. Acute
exercise remodels promoter methylation in human skeletal muscle. Cell
Metab. (2012) 15:405–11. doi: 10.1016/j.cmet.2012.01.001
35. Camera DM, Burniston JG, Pogson MA, Smiles WJ, Hawley JA. Dynamic
proteome profiling of individual proteins in human skeletal muscle
after a high-fat diet and resistance exercise. Faseb J. (2017) 31:5478–94.
doi: 10.1096/fj.201700531R
Frontiers in Neurology | www.frontiersin.org 9 August 2018 | Volume 9 | Article 698
Delezie and Handschin Muscle Secretome and the Brain
36. Choi S, Liu X, Li P, Akimoto T, Lee SY, Zhang M, et al. Transcriptional
profiling in mouse skeletal muscle following a single bout of voluntary
running: evidence of increased cell proliferation. J Appl Physiol. (2005)
99:2406–15. doi: 10.1152/japplphysiol.00545.2005
37. Hody S, Leprince P, Sergeant K, Renaut J, Croisier JL, Wang
F, et al. Human muscle proteome modifications after acute or
repeated eccentric exercises. Med Sci Sports Exerc. (2011) 43:2281–96.
doi: 10.1249/MSS.0b013e318222edf3
38. Laker RC, Garde C, Camera DM, Smiles WJ, Zierath JR, Hawley JA, et al.
Transcriptomic and epigenetic responses to short-term nutrient-exercise
stress in humans. Sci Rep. (2017) 7:15134. doi: 10.1038/s41598-017-15420-7
39. Lundberg TR, Fernandez-Gonzalo R, Tesch PA, Rullman E, Gustafsson
T. Aerobic exercise augments muscle transcriptome profile of resistance
exercise. Am J Physiol Regul Integr Comp Physiol. (2016) 310:R1279–87.
doi: 10.1152/ajpregu.00035.2016
40. Koh JH, Hancock CR, Terada S, Higashida K, Holloszy JO, Han
DH. PPARbeta Is Essential for maintaining normal levels of
PGC-1alpha and mitochondria and for the increase in muscle
mitochondria induced by exercise. Cell Metab. (2017) 25:1176–85.e1175.
doi: 10.1016/j.cmet.2017.04.029
41. Perez-Schindler J, Svensson K, Vargas-Fernandez E, Santos G, Wahli
W, Handschin C. The coactivator PGC-1alpha regulates skeletal muscle
oxidative metabolism independently of the nuclear receptor PPARbeta/delta
in sedentary mice fed a regular chow diet. Diabetologia (2014) 57:2405–12.
doi: 10.1007/s00125-014-3352-3
42. Schuler M, Ali F, Chambon C, Duteil D, Bornert JM, Tardivel A, et al.
PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose
ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell
Metab. (2006) 4:407–14. doi: 10.1016/j.cmet.2006.10.003
43. Wright DC, Han DH, Garcia-Roves PM, Geiger PC, Jones TE, Holloszy
JO. Exercise-induced mitochondrial biogenesis begins before the increase
in muscle PGC-1alpha expression. J Biol Chem. (2007) 282:194–9.
doi: 10.1074/jbc.M606116200
44. Kupr B, Handschin C. Complex coordination of cell plasticity by a PGC-1α-
controlled transcriptional network in skeletal muscle. Front Physiol. (2015)
6:325. doi: 10.3389/fphys.2015.00325
45. Kupr B, Schnyder S, Handschin C. Role of nuclear receptors in exercise-
induced muscle adaptations. Cold Spring Harb Perspect Med. (2017)
7:a029835. doi: 10.1101/cshperspect.a029835
46. Schnyder S, Kupr B, Handschin C. Coregulator-mediated control of
skeletal muscle plasticity - a mini-review. Biochimie (2017) 136:49–54.
doi: 10.1016/j.biochi.2016.12.011
47. Summermatter S, Santos G, Pérez-Schindler J, Handschin C. Skeletal muscle
PGC-1α controls whole-body lactate homeostasis through estrogen-related
receptor α-dependent activation of LDH B and repression of LDH A. Proc
Natl Acad Sci USA (2013) 110:8738–43. doi: 10.1073/pnas.1212976110
48. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G,
et al. HIF-independent regulation of VEGF and angiogenesis by the
transcriptional coactivator PGC-1alpha. Nature (2008) 451:1008–12.
doi: 10.1038/nature06613
49. Chinsomboon J, Ruas J, Gupta RK, Thom R, Shoag J, Rowe GC, et al.
The transcriptional coactivator PGC-1alpha mediates exercise-induced
angiogenesis in skeletal muscle. Proc Natl Acad Sci USA (2009) 106:21401–6.
doi: 10.1073/pnas.0909131106
50. Rowe GC, Raghuram S, Jang C, Nagy JA, Patten IS, Goyal A,
et al. PGC-1α induces SPP1 to activate macrophages and orchestrate
functional angiogenesis in skeletal muscle. Circ Res. (2014) 115:504–17.
doi: 10.1161/CIRCRESAHA.115.303829
51. Arnold AS, Gill J, Christe M, Ruiz R, McGuirk S, St-Pierre J, et al.
Morphological and functional remodelling of the neuromuscular
junction by skeletal muscle PGC-1α. Nat Commun (2014) 5:3569.
doi: 10.1038/ncomms4569
52. Mills R, Taylor-Weiner H, Correia JC, Agudelo LZ, Allodi I, Kolonelou C,
et al. Neurturin is a PGC-1α1-controlled myokine that promotes motor
neuron recruitment and neuromuscular junction formation. Mol Metab.
(2017) 7:12–22. doi: 10.1016/j.molmet.2017.11.001
53. Jäger S, Handschin C, St.-Pierre J, and Spiegelman BM. AMP-
activated protein kinase (AMPK) action in skeletal muscle via direct
phosphorylation of PGC-1α. Proc Natl Acad Sci. (2007) 104:12017–22.
doi: 10.1073/pnas.0705070104
54. Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the
metabolic regulator and transcriptional coactivator PGC-1α. J Biol Chem.
(2005) 280:16456–60. doi: 10.1074/jbc.M501485200
55. Richter EA, Ruderman NB. AMPK and the biochemistry of exercise:
implications for human health and disease. Biochem J. (2009) 418:261–75.
doi: 10.1042/BJ20082055
56. Fan W, Waizenegger W, Lin CS, Sorrentino V, He M-X, Wall CE, et al.
PPARδ promotes running endurance by preserving glucose. Cell Metab.
(2017) 25:1186–93.e1184. doi: 10.1016/j.cmet.2017.04.006
57. Handschin C. Caloric restriction and exercise “mimetics”: ready for prime
time? Pharmacol Res. (2016) 103:158–66. doi: 10.1016/j.phrs.2015.11.009
58. Kobilo T, Yuan C, van Praag H. Endurance factors improve hippocampal
neurogenesis and spatial memory in mice. Learn Mem. (2011) 18:103–7.
doi: 10.1101/lm.2001611
59. Kobilo T, Guerrieri D, Zhang Y, Collica SC, Becker KG, van Praag H. AMPK
agonist AICAR improves cognition and motor coordination in young and
aged mice. Learn Mem. (2014) 21:119–26. doi: 10.1101/lm.033332.113
60. Peluso MAM, Guerra de Andrade LH. Physical activity and mental health:
the association between exercise and mood. Clinics (2005). 60:61–70.
doi: 10.1590/S1807-59322005000100012
61. Taylor CB, Sallis JF, Needle R. The relation of physical activity and exercise
to mental health. Public Health Rep. (1985) 100:195–202.
62. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, et al.
Exercise training increases size of hippocampus and improves memory. Proc
Natl Acad Sci USA. (2011) 108:3017–22. doi: 10.1073/pnas.1015950108
63. Firth J, Stubbs B, Vancampfort D, Schuch F, Lagopoulos J, Rosenbaum
S, et al. Effect of aerobic exercise on hippocampal volume in humans:
a systematic review and meta-analysis. NeuroImage (2018) 166:230–8.
doi: 10.1016/j.neuroimage.2017.11.007
64. Sexton CE, Betts JF, Demnitz N, Dawes H, Ebmeier KP, Johansen-
Berg H. A systematic review of MRI studies examining the relationship
between physical fitness and activity and the white matter of the ageing
brain. Neuroimage (2016) 131:81–90. doi: 10.1016/j.neuroimage.2015.0
9.071
65. van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhances
neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad
Sci USA. (1999) 96:13427–31. doi: 10.1073/pnas.96.23.13427
66. van Praag H, Kempermann G, Gage FH. Running increases cell proliferation
and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci. (1999)
2:266–70. doi: 10.1038/6368
67. Eisinger BE, Zhao X. Identifying molecular mediators of
environmentally enhanced neurogenesis Cell Tissue Res. (2018). 371:7–21.
doi: 10.1007/s00441-017-2718-5
68. Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity:
the synaptic consolidation hypothesis. Prog Neurobiol. (2005) 76:99–125.
doi: 10.1016/j.pneurobio.2005.06.003
69. Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function,
and dysfunction. In: Lewin GR, Carter BD, editors. Neurotrophic Factors.
Berlin; Heidelberg: Springer (2014), p. 223–50.
70. Matsumoto T, Rauskolb S, Polack M, Klose J, Kolbeck R, Korte M,
et al. Biosynthesis and processing of endogenous BDNF: CNS neurons
store and secrete BDNF, not pro-BDNF. Nat Neurosci. (2008) 11:131–3.
doi: 10.1038/nn2038
71. Yang J, Siao CJ, Nagappan G, Marinic T, Jing D, McGrath K, et al. Neuronal
release of proBDNF. Nat Neurosci. (2009) 12:113–5. doi: 10.1038/nn.2244
72. Neeper SA, Góauctemez-Pinilla F, Choi J, Cotman C. Exercise and brain
neurotrophins. Nature (1995) 373:109. doi: 10.1038/373109a0
73. Vaynman S, Ying Z, Gomez-Pinilla F. Hippocampal BDNF mediates the
efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci.
(2004) 20:2580–90. doi: 10.1111/j.1460-9568.2004.03720.x
74. Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E,
et al. Evidence for a release of brain-derived neurotrophic factor
from the brain during exercise. Exp Physiol. (2009) 94:1062–9.
doi: 10.1113/expphysiol.2009.048512
75. Seifert T, Brassard P, Wissenberg M, Rasmussen P, Nordby P, Stallknecht
B, et al. Endurance training enhances BDNF release from the human
Frontiers in Neurology | www.frontiersin.org 10 August 2018 | Volume 9 | Article 698
Delezie and Handschin Muscle Secretome and the Brain
brain. Am J Physiol Regul Integr Comp Physiol. (2009) 298:R372–7.
doi: 10.1152/ajpregu.00525.2009
76. Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A,
Rios M, et al. Blood BDNF concentrations reflect brain-tissue BDNF
levels across species. Int J Neuropsychopharmacol. (2011) 14:347–53.
doi: 10.1017/S1461145710000738
77. Chacón-Fernández P, Säuberli K, ColzaniM,Moreau T, Ghevaert C, Barde Y-
A. Brain-derived neurotrophic factor in megakaryocytes. J Biol Chem. (2016)
291:9872–81. doi: 10.1074/jbc.M116.720029
78. El-Sayed MS, Ali N, El-Sayed Ali Z. Aggregation and activation of
blood platelets in exercise and training. Sports Med. (2005) 35:11–22.
doi: 10.2165/00007256-200535010-00002
79. Yáñez-Mó M, Siljander PRM, Andreu Z, Bedina Zavec A, Borràs FE, Buzas
EI, et al. Biological properties of extracellular vesicles and their physiological
functions. J Extracell Vesicles (2015) 4:27066. doi: 10.3402/jev.v4.27066
80. Ogborn DI, Gardiner PF. Effects of exercise and muscle type on BDNF, NT-
4/5, and TrKB expression in skeletal muscle.Muscle Nerve (2010) 41:385–91.
doi: 10.1002/mus.21503
81. Pedersen BK, Pedersen M, Krabbe KS, Bruunsgaard H, Matthews VB,
Febbraio MA. Role of exercise-induced brain-derived neurotrophic factor
production in the regulation of energy homeostasis inmammals. Exp Physiol.
(2009) 94:1153–60. doi: 10.1113/expphysiol.2009.048561
82. Matthews VB, Astrom MB, Chan MH, Bruce CR, Krabbe KS, Prelovsek
O, et al. Brain-derived neurotrophic factor is produced by skeletal
muscle cells in response to contraction and enhances fat oxidation via
activation of AMP-activated protein kinase. Diabetologia (2009) 52:1409–18.
doi: 10.1007/s00125-009-1364-1
83. Mousavi K, Jasmin BJ. BDNF is expressed in skeletal muscle satellite
cells and inhibits myogenic differentiation. J Neurosci. (2006) 26:5739–49.
doi: 10.1523/JNEUROSCI.5398-05.2006
84. Koliatsos VE, Clatterbuck RE, Winslow JW, Cayouette MH, Price
DL. Evidence that brain-derived neurotrophic factor is a trophic
factor for motor neurons in vivo. Neuron (1993) 10:359–67.
doi: 10.1016/0896-6273(93)90326-M
85. Givalois L, Arancibia S, Alonso G, Tapia-Arancibia L. Expression of
brain-derived neurotrophic factor and its receptors in the median
eminence cells with sensitivity to stress. Endocrinology (2004) 145:4737–47.
doi: 10.1210/en.2004-0616
86. Ding Q, Vaynman S, Akhavan M, Ying Z, Gomez-Pinilla F. Insulin-
like growth factor I interfaces with brain-derived neurotrophic
factor-mediated synaptic plasticity to modulate aspects of exercise-
induced cognitive function. Neuroscience (2006) 140:823–33.
doi: 10.1016/j.neuroscience.2006.02.084
87. Trejo JL, Carro E, Torres-Aleman I. Circulating insulin-like growth
factor I mediates exercise-induced increases in the number of new
neurons in the adult hippocampus. J Neurosci (2001) 21:1628–34.
doi: 10.1523/JNEUROSCI.21-05-01628.2001
88. Cheng A, Wan R, Yang JL, Kamimura N, Son TG, Ouyang X, et al.
Involvement of PGC-1alpha in the formation and maintenance of neuronal
dendritic spines. Nat Commun. (2012) 3:1250. doi: 10.1038/ncomms2238
89. Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D,
et al. Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5
pathway. Cell Metab. (2013) 18:649–59. doi: 10.1016/j.cmet.2013.0
9.008
90. St-Pierre J, Drori S, UldryM, Silvaggi JM, Rhee J, Jager S, et al. Suppression of
reactive oxygen species and neurodegeneration by the PGC-1 transcriptional
coactivators. Cell (2006) 127:397–408. doi: 10.1016/j.cell.2006.09.024
91. Adlard PA, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases
amyloid load in a transgenic model of alzheimer’s disease. J Neurosci. (2005)
25:4217–21. doi: 10.1523/JNEUROSCI.0496-05.2005
92. Pang TY, Stam NC, Nithianantharajah J, Howard ML, Hannan AJ.
Differential effects of voluntary physical exercise on behavioral
and brain-derived neurotrophic factor expression deficits in
Huntington’s disease transgenic mice. Neuroscience (2006) 141:569–84.
doi: 10.1016/j.neuroscience.2006.04.013
93. Praag HV, Shubert T, Zhao C, Gage FH. Exercise enhances learning and
hippocampal neurogenesis in aged mice. J Neurosci Official J Soc Neurosci.
(2005)25:8680–5. doi: 10.1523/JNEUROSCI.1731-05.2005
94. Duzel E, van Praag H, Sendtner M. Can physical exercise in old age
improve memory and hippocampal function? Brain (2016) 139:662–73.
doi: 10.1093/brain/awv407
95. Erickson KI, Prakash RS, Voss MW, Chaddock L, Hu L, Morris KS, et al.
Aerobic fitness is associated with hippocampal volume in elderly humans.
Hippocampus (2009) 19:1030–9. doi: 10.1002/hipo.20547
96. Prakash RS, Voss MW, Erickson KI, Kramer AF. Physical activity
and cognitive vitality. Annu Rev Psychol. (2015) 66:769–97.
doi: 10.1146/annurev-psych-010814-015249
97. Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal
neurogenesis. J Comp Neurol. (2000) 425:479–94. doi: 10.1002/1096-
9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
98. Kraus RM, Stallings HW, Yeager RC, Gavin TP. Circulating plasma VEGF
response to exercise in sedentary and endurance-trained men. J Appl Physiol.
(2004) 96:1445–50. doi: 10.1152/japplphysiol.01031.2003
99. Fabel K, Fabel K, Tam B, Kaufer D, Baiker A, Simmons N, et al. VEGF
is necessary for exercise-induced adult hippocampal neurogenesis. Eur J
Neurosci. (2003) 18:2803–12. doi: 10.1111/j.1460-9568.2003.03041.x
100. Gomez-Pinilla F, Ying Z, Opazo P, Roy RR, Edgerton VR.
Differential regulation by exercise of BDNF and NT-3 in rat
spinal cord and skeletal muscle. Eur J Neurosci. (2001) 13:1078–84.
doi: 10.1046/j.0953-816x.2001.01484.x
101. McCullough MJ, Peplinski NG, Kinnell KR, Spitsbergen JM. Glial cell line-
derived neurotrophic factor protein content in rat skeletal muscle is altered
by increased physical activity in vivo and in vitro. Neuroscience (2011)
174:234–44. doi: 10.1016/j.neuroscience.2010.11.016
102. Tajiri N, Yasuhara T, Shingo T, Kondo A, Yuan W, Kadota T, et al. Exercise
exerts neuroprotective effects on Parkinson’s disease model of rats. Brain Res.
(2010) 1310:200–7. doi: 10.1016/j.brainres.2009.10.075
103. Ying Z, Roy RR, Edgerton VR, Gomez-Pinilla F. Voluntary exercise increases
neurotrophin-3 and its receptor TrkC in the spinal cord. Brain Res. (2003)
987:93–9. doi: 10.1016/S0006-8993(03)03258-X
104. Phillips C, Baktir MA, Srivatsan M, Salehi A. Neuroprotective effects of
physical activity on the brain: a closer look at trophic factor signaling. Front
Cell Neurosci. (2014) 8:170. doi: 10.3389/fncel.2014.00170
105. FebbraioMA, Hiscock N, Sacchetti M, Fischer CP, Pedersen BK. Interleukin-
6 is a novel factor mediating glucose homeostasis during skeletal muscle
contraction. Diabetes (2004) 53:1643–8. doi: 10.2337/diabetes.53.7.1643
106. Catoire M, Mensink M, Kalkhoven E, Schrauwen P, Kersten S. Identification
of human exercise-induced myokines using secretome analysis. Physiol
Genomics (2014) 46:256–67. doi: 10.1152/physiolgenomics.00174.2013
107. Raschke S, Eckardt K, Bjorklund Holven K, Jensen J, Eckel J. Identification
and validation of novel contraction-regulated myokines released from
primary human skeletal muscle cells. PLoS ONE (2013) 8:e62008.
doi: 10.1371/journal.pone.0062008
108. Scheler M, Irmler M, Lehr S, Hartwig S, Staiger H, Al-Hasani H,
et al. Cytokine response of primary human myotubes in an in vitro
exercise model. Am J Physiol Cell Physiol. (2013) 305:C877–886.
doi: 10.1152/ajpcell.00043.2013
109. Norheim F, Raastad T, Thiede B, Rustan AC, Drevon CA, Haugen F.
Proteomic identification of secreted proteins from human skeletal muscle
cells and expression in response to strength training.Am J Physiol Endocrinol
Metab. (2011) 301:E1013–21. doi: 10.1152/ajpendo.00326.2011
110. Roca-Rivada A, Al-Massadi O, Castelao C, Senin LL, Alonso J, Seoane LM,
et al. Muscle tissue as an endocrine organ: comparative secretome profiling of
slow-oxidative and fast-glycolytic rat muscle explants and its variation with
exercise. J Proteomics (2012) 75:5414–25. doi: 10.1016/j.jprot.2012.06.037
111. Pourteymour S, Eckardt K, Holen T, Langleite T, Lee S, Jensen J,
et al. Global mRNA sequencing of human skeletal muscle: search
for novel exercise-regulated myokines. Mol Metab. (2017) 6:352–65.
doi: 10.1016/j.molmet.2017.01.007
112. Schnyder S, Handschin C. Skeletal muscle as an endocrine
organ: PGC-1α, myokines and exercise. Bone (2015) 80:115–25.
doi: 10.1016/j.bone.2015.02.008
113. Roberts LD, Bostrom P, O’Sullivan JF, Schinzel RT, Lewis GD, Dejam A, et al.
β -Aminoisobutyric acid induces browning of white fat and hepatic beta-
oxidation and is inversely correlated with cardiometabolic risk factors. Cell
Metab. (2014) 19:96–108. doi: 10.1016/j.cmet.2013.12.003
Frontiers in Neurology | www.frontiersin.org 11 August 2018 | Volume 9 | Article 698
Delezie and Handschin Muscle Secretome and the Brain
114. Moon HY, Becke A, Berron D, Becker B, Sah N, Benoni G, et al. Running-
induced systemic cathepsin B secretion is associated with memory function.
Cell Metab. (2016) 24:332–40. doi: 10.1016/j.cmet.2016.05.025
115. Morland C, Andersson KA, Haugen OP, Hadzic A, Kleppa L, Gille A, et al.
Exercise induces cerebral VEGF and angiogenesis via the lactate receptor
HCAR1. Nat Commun. (2017) 8:15557. doi: 10.1038/ncomms15557
116. Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, Stringer
T, et al. Exercise promotes the expression of brain derived neurotrophic
factor (BDNF) through the action of the ketone body β-hydroxybutyrate.
Elife (2016) 5:e15092. doi: 10.7554/eLife.15092
117. Bookout AL, de Groot MH, Owen BM, Lee S, Gautron L, Lawrence HL, et al.
FGF21 regulatesmetabolism and circadian behavior by acting on the nervous
system. Nat Med. (2013) 19:1147–52. doi: 10.1038/nm.3249
118. Kim KH, Kim SH, Min YK, Yang HM, Lee JB, Lee MS. Acute exercise
induces FGF21 expression in mice and in healthy humans. PLoS ONE (2013)
8:e63517. doi: 10.1371/journal.pone.0063517
119. Owen BM, Ding X, Morgan DA, Coate KC, Bookout AL, Rahmouni
K, et al. FGF21 acts centrally to induce sympathetic nerve activity,
energy expenditure, and weight loss. Cell Metab. (2014) 20:670–7.
doi: 10.1016/j.cmet.2014.07.012
120. Carro E, Nunez A, Busiguina S, Torres-Aleman I. Circulating insulin-like
growth factor I mediates effects of exercise on the brain. J Neurosci (2000)
20:2926–33. doi: 10.1523/JNEUROSCI.20-08-02926.2000
121. Agudelo LZ, Femenia T, Orhan F, Porsmyr-Palmertz M, Goiny M,
Martinez-Redondo V, et al. Skeletal muscle PGC-1α1 modulates kynurenine
metabolism andmediates resilience to stress-induced depression. Cell (2014)
159:33–45. doi: 10.1016/j.cell.2014.07.051
122. Schlittler M, Goiny M, Agudelo LZ, Venckunas T, Brazaitis M, Skurvydas
A, et al. Endurance exercise increases skeletal muscle kynurenine
aminotransferases and plasma kynurenic acid in humans. Am J Physiol Cell
Physiol. (2016) 310:C836–40. doi: 10.1152/ajpcell.00053.2016
123. Ehlen JC, Brager AJ, Baggs J, Pinckney L, Gray CL, DeBruyne JP, et al.
Bmal1 function in skeletal muscle regulates sleep. Elife (2017) 6:e26557.
doi: 10.7554/eLife.26557
124. Ferrer-Martinez A, Ruiz-Lozano P, Chien KR. Mouse PeP: a novel
peroxisomal protein linked to myoblast differentiation and development.
Dev Dyn. (2002) 224:154–67. doi: 10.1002/dvdy.10099
125. Teufel A, Malik N, Mukhopadhyay M, Westphal H. Frcp1 and Frcp2, two
novel fibronectin type III repeat containing genes. Gene (2002) 297:79–83.
doi: 10.1016/S0378-1119(02)00828-4
126. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-
dependent myokine that drives brown-fat-like development of white fat and
thermogenesis. Nature (2012) 481:463–8. doi: 10.1038/nature10777
127. Jedrychowski MP, Wrann CD, Paulo JA, Gerber KK, Szpyt J, Robinson
MM, et al. Detection and Quantitation of Circulating Human
Irisin by Tandem Mass Spectrometry. Cell Metab (2015) 22:734–40.
doi: 10.1016/j.cmet.2015.08.001
128. Lee P, Linderman JD, Smith S, Brychta RJ, Wang J, Idelson C, et al.
Irisin and FGF21 are cold-induced endocrine activators of brown fat
function in humans. Cell Metab. (2014) 19:302–9. doi: 10.1016/j.cmet.2013.1
2.017
129. Perakakis N, Triantafyllou GA, Fernandez-Real JM, Huh JY, Park KH,
Seufert J, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev
Endocrinol. (2017) 13:324–37. doi: 10.1038/nrendo.2016.221
130. Hashemi MS, Ghaedi K, Salamian A, Karbalaie K, Emadi-Baygi M, Tanhaei
S, et al. Fndc5 knockdown significantly decreased neural differentiation
rate of mouse embryonic stem cells. Neuroscience (2013) 231:296–304.
doi: 10.1016/j.neuroscience.2012.11.041
131. Zhang W, Chang L, Zhang C, Zhang R, Li Z, Chai B, et al. Central and
peripheral irisin differentially regulate blood pressure. Cardiovasc Drugs
Ther. (2015) 29:121–7. doi: 10.1007/s10557-015-6580-y
132. Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, et al. Cysteine
cathepsins: from structure, function and regulation to new frontiers. Biochim
Biophys Acta (2012) 1824:68–88. doi: 10.1016/j.bbapap.2011.10.002
133. Aggarwal N, Sloane BF. Cathepsin B: multiple roles in cancer. Proteomics
Clin Appl. (2014) 8:427–37. doi: 10.1002/prca.201300105
134. Theocharis AD, Gialeli C, Bouris P, Giannopoulou E, Skandalis SS, Aletras
AJ, et al. Cell-matrix interactions: focus on proteoglycan-proteinase interplay
and pharmacological targeting in cancer. FEBS J. (2014) 281:5023–42.
doi: 10.1111/febs.12927
135. Lauritzen KH, Morland C, Puchades M, Holm-Hansen S, Hagelin
EM, Lauritzen F, et al. Lactate receptor sites link neurotransmission,
neurovascular coupling, and brain energy metabolism. Cereb Cortex (2014)
24:2784–95. doi: 10.1093/cercor/bht136
136. Wang L, Chopp M, Gregg SR, Zhang RL, Teng H, Jiang A, et al.
Neural progenitor cells treated with EPO induce angiogenesis through
the production of VEGF. J Cereb Blood Flow Metab. (2008) 28:1361–8.
doi: 10.1038/jcbfm.2008.32
137. Hall CN, Reynell C, Gesslein B, Hamilton NB,Mishra A, Sutherland BA, et al.
Capillary pericytes regulate cerebral blood flow in health and disease. Nature
(2014) 508:55–60. doi: 10.1038/nature13165
138. Craft LL, Perna FM. The benefits of exercise for the clinically
depressed. Prim Care Companion J Clin Psychiatry (2004) 6:104–11.
doi: 10.4088/PCC.v06n0301
139. Josefsson T, Lindwall M, Archer T. Physical exercise intervention in
depressive disorders: meta-analysis and systematic review. Scand J Med Sci
Sports (2014) 24:259–72. doi: 10.1111/sms.12050
140. Reus GZ, Jansen K, Titus S, Carvalho AF, Gabbay V, Quevedo J. Kynurenine
pathway dysfunction in the pathophysiology and treatment of depression:
Evidences from animal and human studies. J Psychiatr Res (2015) 68:316–28.
doi: 10.1016/j.jpsychires.2015.05.007
141. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the
mammalian brain: when physiology meets pathology. Nat Rev Neurosci.
(2012) 13:465–77. doi: 10.1038/nrn3257
142. Cotman CW, Berchtold NC, Christie L-A. Exercise builds brain health: key
roles of growth factor cascades and inflammation. Trends in Neurosciences
(2007) 30:464–72. doi: 10.1016/j.tins.2007.06.011
143. Di Benedetto S, Müller L, Wenger E, Düzel S, Pawelec G. Contribution
of neuroinflammation and immunity to brain aging and the mitigating
effects of physical and cognitive interventions.NeurosciBiobehavl Rev. (2017)
75:114–28. doi: 10.1016/j.neubiorev.2017.01.044
144. Svensson K, Albert V, Cardel B, Salatino S, Handschin C. Skeletal
muscle PGC-1α modulates systemic ketone body homeostasis and
ameliorates diabetic hyperketonemia in mice. Faseb J. (2016) 30:1976–86.
doi: 10.1096/fj.201500128
145. Koppel I, Timmusk T. Differential regulation of Bdnf
expression in cortical neurons by class-selective histone
deacetylase inhibitors. Neuropharmacology (2013) 75:106–15.
doi: 10.1016/j.neuropharm.2013.07.015
146. Chavan R, Feillet C, Costa SS, Delorme JE, Okabe T, Ripperger JA, et al. Liver-
derived ketone bodies are necessary for food anticipation. Nat Commun.
(2016) 7:10580. doi: 10.1038/ncomms10580
147. Brown RE, Basheer R, McKenna JT, Strecker RE, McCarley RW.
Control of sleep and wakefulness. Physiol Rev. (2012) 92:1087–187.
doi: 10.1152/physrev.00032.2011
148. Partch CL, Green CB, Takahashi JS. Molecular architecture of
the mammalian circadian clock. Trends Cell Biol. (2014) 24:90–9.
doi: 10.1016/j.tcb.2013.07.002
149. Naylor E, Bergmann BM, Krauski K, Zee PC, Takahashi JS, Vitaterna MH,
et al. The circadian clock mutation alters sleep homeostasis in the mouse. J
Neurosci. (2000) 20:8138–43. doi: 10.1523/JNEUROSCI.20-21-08138.2000
150. Patke A, Murphy PJ, Onat OE, Krieger AC, Ozcelik T, Campbell SS, et al.
Mutation of the human circadian clock gene CRY1 in familial delayed sleep
phase disorder. Cell (2017) 169:203–15 e213. doi: 10.1016/j.cell.2017.03.027
151. Laposky A, Easton A, Dugovic C, Walisser J, Bradfield C, Turek F. Deletion
of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep
architecture and the response to sleep deprivation. Sleep (2005) 28:395–409.
doi: 10.1093/sleep/28.4.395
152. Dyar KA, Ciciliot S, Wright LE, Bienso RS, Tagliazucchi GM, Patel
VR, et al. Muscle insulin sensitivity and glucose metabolism are
controlled by the intrinsic muscle clock. Mol Metab. (2014) 3:29–41.
doi: 10.1016/j.molmet.2013.10.005
153. Harfmann BD, Schroder EA, Kachman MT, Hodge BA, Zhang X, Esser
KA. Muscle-specific loss of Bmal1 leads to disrupted tissue glucose
metabolism and systemic glucose homeostasis. Skelet Muscle (2016) 6:12.
doi: 10.1186/s13395-016-0082-x
Frontiers in Neurology | www.frontiersin.org 12 August 2018 | Volume 9 | Article 698
Delezie and Handschin Muscle Secretome and the Brain
154. McDearmon EL, Patel KN, Ko CH, Walisser JA, Schook AC, Chong
JL, et al. Dissecting the functions of the mammalian clock protein
BMAL1 by tissue-specific rescue in mice. Science (2006) 314:1304–8.
doi: 10.1126/science.1132430
155. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G,
et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans
and glucose uptake and fatty acid oxidation in vitro via AMP-activated
protein kinase. Diabetes (2006) 55:2688–97. doi: 10.2337/db05-1404
156. Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT,
et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like
peptide-1 secretion from L cells and alpha cells. Nat Med. (2011) 17:1481–9.
doi: 10.1038/nm.2513
157. Wueest S, Item F, Boyle CN, Jirkof P, Cesarovic N, Ellingsgaard H, et al.
Interleukin-6 contributes to early fasting-induced free fatty acidmobilization
in mice. Am J Physiol Regul Integr Comp Physiol. (2014) 306:R861–7.
doi: 10.1152/ajpregu.00533.2013
158. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal
muscle as a secretory organ. Nat Rev Endocrinol. (2012) 8:457–65.
doi: 10.1038/nrendo.2012.49
159. Banks WA. Blood-brain barrier transport of cytokines: a
mechanism for neuropathology. Curr Pharm Des. (2005) 11:973–84.
doi: 10.2174/1381612053381684
160. Calabrese F, Rossetti AC, Racagni G, Gass P, Riva MA,
Molteni R. Brain-derived neurotrophic factor: a bridge between
inflammation and neuroplasticity. Front Cell Neurosci. (2014) 8:430.
doi: 10.3389/fncel.2014.00430
161. Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front
Neuroendocrinol. (2012) 33:116–25. doi: 10.1016/j.yfrne.2011.12.002
162. Fisher FM, Maratos-Flier E. Understanding the Physiology of FGF21. Annu
Rev Physiol. (2016) 78:223–41. doi: 10.1146/annurev-physiol-021115-105339
163. Hsuchou H, Pan W, Kastin AJ. The fasting polypeptide
FGF21 can enter brain from blood. Peptides (2007) 28:2382–6.
doi: 10.1016/j.peptides.2007.10.007
164. Tan BK, HallschmidM, Adya R, KernW, Lehnert H, Randeva HS. Fibroblast
growth factor 21 (FGF21) in human cerebrospinal fluid: relationship
with plasma FGF21 and body adiposity. Diabetes (2011) 60:2758–62.
doi: 10.2337/db11-0672
165. Sa-Nguanmoo P, Tanajak P, Kerdphoo S, Satjaritanun P, Wang X, Liang
G, et al. FGF21 improves cognition by restored synaptic plasticity,
dendritic spine density, brain mitochondrial function and cell apoptosis
in obese-insulin resistant male rats. Horm Behav. (2016) 85:86–95.
doi: 10.1016/j.yhbeh.2016.08.006
166. Guridi M, Tintignac LA, Lin S, Kupr B, Castets P, Ruegg MA. Activation
of mTORC1 in skeletal muscle regulates whole-body metabolism through
FGF21. Sci Signal (2015) 8:ra113. doi: 10.1126/scisignal.aab3715
167. Harris LA, Skinner JR, Shew TM, Pietka TA, Abumrad NA, Wolins NE.
Perilipin 5-driven lipid droplet accumulation in skeletal muscle stimulates
the expression of fibroblast growth factor 21. Diabetes (2015) 64:2757–68.
doi: 10.2337/db14-1035
168. Izumiya Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A, Walsh
K. FGF21 is an Akt-regulated myokine. FEBS Lett. (2008) 582:3805–10.
doi: 10.1016/j.febslet.2008.10.021
169. Keipert S, Ost M, Johann K, Imber F, Jastroch M, van Schothorst EM,
et al. Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk
through the induction of FGF21 as a myokine. Am J Physiol Endocrinol
Metab. (2014) 306:E469–82. doi: 10.1152/ajpendo.00330.2013
170. Pereira RO, Tadinada SM, Zasadny FM, Oliveira KJ, Pires KMP, Olvera
A, et al. OPA1 deficiency promotes secretion of FGF21 from muscle
that prevents obesity and insulin resistance. EMBO J. (2017) 36:2126–45.
doi: 10.15252/embj.201696179
171. Estall JL, Ruas JL, Choi CS, Laznik D, Badman M, Maratos-Flier E, et al.
PGC-1α negatively regulates hepatic FGF21 expression by modulating
the heme/Rev-Erb(α) axis. Proc Natl Acad Sci USA. (2009) 106:22510–5.
doi: 10.1073/pnas.0912533106
172. Wu J, Ruas JL, Estall JL, Rasbach KA, Choi JH, Ye L, et al. The
unfolded protein response mediates adaptation to exercise in skeletal
muscle through a PGC-1α/ATF6α complex. Cell Metab. (2011) 13:160–9.
doi: 10.1016/j.cmet.2011.01.003
173. Cianferotti L, Brandi ML. Muscle-bone interactions: basic and clinical
aspects. Endocrine (2014) 45:165–77. doi: 10.1007/s12020-013-0026-8
174. Karasik D, Kiel DP. Evidence for pleiotropic factors in
genetics of the musculoskeletal system. Bone (2010) 46:1226–37.
doi: 10.1016/j.bone.2010.01.382
175. Novotny SA, Warren GL, Hamrick MW. Aging and the muscle-bone
relationship. Physiology (2015) 30:8–16. doi: 10.1152/physiol.00033.2014
176. Brotto M, Bonewald L. Bone and muscle: Interactions beyond mechanical.
Bone (2015) 80:109–14. doi: 10.1016/j.bone.2015.02.010
177. Lee NK, Sowa H, Hinoi E, FerronM, Ahn JD, Confavreux C, et al. Endocrine
regulation of energy metabolism by the skeleton. Cell (2007) 130:456–69.
doi: 10.1016/j.cell.2007.05.047
178. Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galan-Diez M,
et al. Osteocalcin signaling in myofibers is necessary and sufficient
for optimum adaptation to exercise. Cell Metab. (2016) 23:1078–92.
doi: 10.1016/j.cmet.2016.05.004
179. Mosialou I, Shikhel S, Liu JM, Maurizi A, Luo N, He Z, et al. MC4R-
dependent suppression of appetite by bone-derived lipocalin 2. Nature
(2017) 543:385–90. doi: 10.1038/nature21697
180. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al.
Lipocalin 2 mediates an innate immune response to bacterial infection by
sequestrating iron. Nature (2004) 432:917–21. doi: 10.1038/nature03104
181. Furrer R, Eisele PS, Schmidt A, Beer M, Handschin C. Paracrine cross-talk
between skeletal muscle and macrophages in exercise by PGC-1α-controlled
BNP. Sci Rep. (2017) 7:40789. doi: 10.1038/srep40789
182. Yau SY, Li A, Hoo RL, Ching YP, Christie BR, Lee TM, et al. Physical exercise-
induced hippocampal neurogenesis and antidepressant effects are mediated
by the adipocyte hormone adiponectin. Proc Natl Acad Sci USA. (2014)
111:15810–5. doi: 10.1073/pnas.1415219111
183. Quinn LS, Strait-Bodey L, Anderson BG, Argiles JM, Havel PJ. Interleukin-
15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a
skeletal muscle-to-fat signaling pathway. Cell Biol Int. (2005) 29:449–57.
doi: 10.1016/j.cellbi.2005.02.005
184. Longo VD, Panda S. Fasting, circadian rhythms, and time-
restricted feeding in healthy lifespan. Cell Metab. (2016) 23:1048–59.
doi: 10.1016/j.cmet.2016.06.001
185. Bass J, Lazar MA. Circadian time signatures of fitness and disease. Science
(2016) 354:994–9. doi: 10.1126/science.aah4965
186. Bedrosian TA, Fonken LK, Nelson RJ. Endocrine effects of
circadian disruption. Annu Rev Physiol. (2016) 78:109–31.
doi: 10.1146/annurev-physiol-021115-105102
187. McClung CA. Circadian genes, rhythms and the biology of mood disorders.
Pharmacol Ther. (2007) 114:222–32. doi: 10.1016/j.pharmthera.2007.02.003
188. Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm
disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci.
(2010) 11:589–99. doi: 10.1038/nrn2868
189. Andrews JL, Zhang X, McCarthy JJ, McDearmon EL, Hornberger TA,
Russell B, et al. CLOCK and BMAL1 regulate MyoD and are necessary for
maintenance of skeletal muscle phenotype and function. Proc Natl Acad Sci
USA. (2010) 107:19090–5. doi: 10.1073/pnas.1014523107
190. Loizides-Mangold U, Perrin L, Vandereycken B, Betts JA, Walhin J-P,
Templeman I, et al. Lipidomics reveals diurnal lipid oscillations in human
skeletal muscle persisting in cellular myotubes cultured in vitro. Proc Natl
Acad Sci USA. (2017) 114:E8565–74. doi: 10.1073/pnas.1705821114
191. Woldt E, Sebti Y, Solt LA, Duhem C, Lancel S, Eeckhoute J, et al.
Rev-erb-α modulates skeletal muscle oxidative capacity by regulating
mitochondrial biogenesis and autophagy. Nat Med. (2013) 19:1039–46.
doi: 10.1038/nm.3213
192. Aoyama S, Shibata S. The role of circadian rhythms in muscular and osseous
physiology and their regulation by nutrition and exercise. Front Neurosci.
(2017) 11:63. doi: 10.3389/fnins.2017.00063
193. Wolff G, Esser KA. Scheduled exercise phase shifts the circadian
clock in skeletal muscle. Med Sci Sports Exerc. (2012) 44:1663–70.
doi: 10.1249/MSS.0b013e318255cf4c
194. Perrin L, Loizides-Mangold U, Skarupelova S, Pulimeno P, Chanon S, Robert
M, et al. Human skeletal myotubes display a cell-autonomous circadian
clock implicated in basal myokine secretion. Mol Metab. (2015) 4:834–45.
doi: 10.1016/j.molmet.2015.07.009
Frontiers in Neurology | www.frontiersin.org 13 August 2018 | Volume 9 | Article 698
Delezie and Handschin Muscle Secretome and the Brain
195. Liu C, Li S, Liu T, Borjigin J, Lin JD. Transcriptional coactivator PGC-
1α integrates the mammalian clock and energy metabolism. Nature (2007)
447:477–81. doi: 10.1038/nature05767
196. Eckel-Mahan K, Sassone-Corsi P. Metabolism and the circadian clock
converge. Physiol Rev. (2013) 93:107–35. doi: 10.1152/physrev.00016.2012
197. Gerstner JR, Lyons LC, Wright KP, Loh DH, Rawashdeh O, Eckel-Mahan
KL, et al. Cycling behavior and memory formation. J Neurosci. (2009)
29:12824–30. doi: 10.1523/JNEUROSCI.3353-09.2009
198. Jilg A, Lesny S, Peruzki N, Schwegler H, Selbach O, Dehghani
F, et al. Temporal dynamics of mouse hippocampal clock gene
expression support memory processing. Hippocampus (2010) 20:377–88.
doi: 10.1002/hipo.20637
199. Marpegan L, Swanstrom AE, Chung K, Simon T, Haydon PG, Khan SK,
et al. Circadian regulation of ATP release in astrocytes. J Neurosci.(2011)
31:8342–50. doi: 10.1523/JNEUROSCI.6537-10.2011
200. Musiek ES, Lim MM, Yang G, Bauer AQ, Qi L, Lee Y, et al. Circadian clock
proteins regulate neuronal redox homeostasis and neurodegeneration. J Clin
Invest. (2013) 123:5389–400. doi: 10.1172/JCI70317
201. Valnegri P, Khelfaoui M, Dorseuil O, Bassani S, Lagneaux C, Gianfelice
A, et al. A circadian clock in hippocampus is regulated by interaction
between oligophrenin-1 and Rev-erbalpha. Nat Neurosci. (2011) 14:1293–
301. doi: 10.1038/nn.2911
202. Catoire M, Kersten S. The search for exercise factors in
humans. FASEB J. (2015) 29:1615–28. doi: 10.1096/fj.14-2
63699
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Delezie and Handschin. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original publication
in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Neurology | www.frontiersin.org 14 August 2018 | Volume 9 | Article 698
